Home > National drug related death database (Scotland): analysis of deaths registered in 2021 and 2022.

Public Health Scotland. (2026) National drug related death database (Scotland): analysis of deaths registered in 2021 and 2022. Edinburgh: Public Health Scotland.

[img]
Preview
PDF (Scotland: analysis of deaths registered in 2021 and 2022.) - Published Version
1MB

External website: https://publichealthscotland.scot/publications/nat...


In Scotland, the numbers of DRDs registered annually increased throughout the 2010s, peaking in 2020. Although decreases were recorded in the reported years 2021 and 2022, the number of deaths remains tragically high.

Scotland has a cohort of people with problematic drug use who have multiple complex health and social care needs. Many people who had a DRD shared similar characteristics: they were male, aged over 35, socially deprived, lived alone and had a history of long term and/or injecting opioid use and near fatal overdose.

Among DRDs registered in 2022:

  • The average age of people who died was 44 years old (an increase from 39 years in 2012).
  • Over half (52%) of the people who died resided in the 20% most deprived neighbourhoods in Scotland (Scottish Index of Multiple Deprivation quintile 1).
  • Four out of five people (81%) who had a DRD lived in their own home. Over half (60%) lived alone all of the time.
  • 387 children were reported to have lost a parent or parental figure as a result of a DRD.
  • Two thirds (65%) of people (73% of those whose death was opioid-related) were in contact with a service (drug treatment, prison or police custody, or discharged from hospital) with the potential to address their problematic drug use or deliver harm reduction interventions in the six months before death.
  • Around three in ten (29%) people who died had an been discharged from an inpatient stay in a general acute hospital in the six months before death.
  • In the six months prior to death, 54% of people who died had a medical condition recorded (respiratory illness, epilepsy, back pain/injury, and blood borne viruses were most common) and 50% had a recent psychiatric condition (depression and anxiety were most common).
  • Over four in ten people (41%) were prescribed an Opioid Substitution Therapy (OST) drug (mainly methadone) at the time of death. The percentage of people who were prescribed an OST at the time of death has increased since 2012 (27%).
  • Methadone (an OST medication) was implicated in 47% of DRDs registered in Scotland.
  • Etizolam (a 'street' benzodiazepine) implication decreased sharply from 58% in 2021 to 38% in 2022, following international prohibition in 2021. Changes in the overall number of DRDs closely mirrored trends in 'street' benzodiazepine implication, suggesting an association between availability and harms.
  • The number of DRDs where cocaine was implicated increased across the time series, to 36% in 2022. Cocaine was implicated in roughly half (49%) of DRDs among people aged under 25 years.

Repository Staff Only: item control page